EGFpeeling I
- Conditions
- Acne scarring, melasm, or other injuries that require chemical peeling.
- Registration Number
- RPCEC00000107
- Lead Sponsor
- Center for Genetic Engineering and Biotechnology (CIGB), in Havana.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
1.Informed consent. 2.Age major than 20 years old, both sexes. 3.Skin diseases that affect facial aesthetics and require peel. 4.Fitzpatrick skin type classification I to IV.
1.Active lesions of acne vulgaris that require treatment or patient with them in the last 6 months. 2.Fitzpatrick skin type classification V-VI. 3.Infection requiring antibiotic treatment or active herpes virus infection. 4.Another skin disease affecting the face. For example: neurotic excoriation. 5.Personal history of keloids or others defect of healing. 6.Diabetes mellitus, erythematosus lupus or some others systemic disease that concern general compliance (liver disease, renal disease, pancreatic disease, colagenosis, anemia, etc.). 7.Malignancies (except the basal cell carcinoma and the cervix cancer in situ after surgery and complete cured). 8.Serious hypertension or heart disease. 9.Previous treatment with steroids in the last 3 months. 10.Previous treatment with EGF in the last 30 days. 11.Previous treatment in the last 6 months like this: isotretinoin, chemical peels, aesthetic or surgical procedure of the head or neck. 12.Serious psychiatric disorder and other disease that limit informed consent. 13.Patient exposed to ultraviolet radiation due to their occupation. 14.Pregnancy and lactation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to healing, 1 month after treatment.
- Secondary Outcome Measures
Name Time Method Quality of healing, one year after treatment. Adverse events during the period for completion of media peels, a month after treatment and follow-up a year.